Clinical Trial Update: Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics, safety and tolerability study of abacavir/dolutegravir/lamivudine fixed-dose combination tablets in healthy Japanese subjects has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Abacavir/dolutegravir/lamivudine fixed-dose combination tablet (Abacavir/dolutegravir/lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED